Wells Fargo & Company Lowers Agilon Health (NYSE:AGL) Price Target to $1.00

Agilon Health (NYSE:AGL) had its target price lowered by equities researchers at Wells Fargo & Company from $1.50 to $1.00 in a report released on Wednesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. Wells Fargo & Company‘s target price points to a potential upside of 23.30% from the stock’s current price.

A number of other equities analysts also recently weighed in on AGL. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Agilon Health in a research note on Wednesday, October 8th. Barclays cut their price target on Agilon Health from $3.00 to $1.50 and set an “underweight” rating on the stock in a research note on Wednesday, August 6th. Benchmark lowered their price objective on Agilon Health from $4.00 to $1.50 and set a “buy” rating for the company in a research note on Wednesday, August 6th. Jefferies Financial Group dropped their target price on Agilon Health from $2.40 to $1.10 and set a “hold” rating on the stock in a report on Friday, August 15th. Finally, Robert W. Baird reduced their price target on Agilon Health from $5.00 to $1.00 and set a “neutral” rating for the company in a report on Thursday, August 14th. Four research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, Agilon Health presently has an average rating of “Hold” and an average target price of $2.77.

Agilon Health Trading Up 12.0%

NYSE AGL traded up $0.09 on Wednesday, hitting $0.81. The company’s stock had a trading volume of 3,877,526 shares, compared to its average volume of 7,158,808. The firm has a market cap of $336.09 million, a P/E ratio of -1.05 and a beta of 0.05. Agilon Health has a 52-week low of $0.71 and a 52-week high of $6.08. The company’s 50-day simple moving average is $1.06 and its 200 day simple moving average is $1.86.

Agilon Health (NYSE:AGL) last announced its quarterly earnings results on Tuesday, November 4th. The company reported ($0.27) EPS for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.09). Agilon Health had a negative return on equity of 66.76% and a negative net margin of 5.35%.The business had revenue of $1.44 billion during the quarter, compared to analysts’ expectations of $1.43 billion. Agilon Health has set its FY 2025 guidance at EPS. On average, research analysts forecast that Agilon Health will post -0.59 EPS for the current fiscal year.

Institutional Trading of Agilon Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in AGL. Arrowpoint Investment Partners Singapore Pte. Ltd. bought a new stake in shares of Agilon Health during the second quarter valued at approximately $31,000. 111 Capital bought a new position in shares of Agilon Health during the 2nd quarter valued at about $36,000. Pilgrim Partners Asia Pte Ltd purchased a new position in shares of Agilon Health during the third quarter valued at about $37,000. Independent Advisor Alliance bought a new stake in Agilon Health in the 3rd quarter worth approximately $39,000. Finally, Nisa Investment Advisors LLC grew its holdings in shares of Agilon Health by 244.9% in the first quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company’s stock valued at $41,000 after purchasing an additional 6,783 shares in the last quarter.

About Agilon Health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.